William Kelly, M.D., a medical oncologist specializing in neuro-oncology and thoracic oncology at The University of Texas Health Science Center at San Antonio, received a $1.5 million CPRIT Early Clinical Investigator grant (RP210164) in 2021. His research focuses on translating existing drugs, which have shown benefit in other types of cancer, into therapies for tumors of the central nervous system.